A new study says the rate of genital herpes infections in the United States is declining.
The Centers for Disease Control says 17 percent of Americans had HSV-2 between 1999 and 2004, down from 21 percent between 1988 and 1994, WebMD reported.
The CDC study -- published in the current issue of The Journal of the American Medical Association -- is based on actual blood samples. WebMD said the report supports recent studies documenting a reduction in high-risk sex among teens.
The study also found a reduction in the rate of infection with HSV-1, the virus that causes cold sores. HSV-1, fell from 62 percent between 1988 and 1994, to 57.7 between 1999 and 2004.
The researchers warn, however, that the herpes virus that causes cold sores may one day become an important cause of genital herpes. The study says an increase in teen oral sex, which is attributed to helping reduce the rate of HSV-2, may be increasing genital infections with HSV-1.
Copyright 2006 by United Press International
Related stories:
Herpes medication does not reduce risk of HIV infection in individuals with HSV-2
An international clinical trial has found that acyclovir, a common medication for treating herpes simplex virus-2 (HSV-2), the most common cause of genital herpes, does not reduce the risk of HIV infection when taken by people infected with HSV-2. Multiple studies have shown that people with HSV-2 have a higher risk of acquiring HIV.
Herpes on the rise in Australia
One in eight Australian adults has been infected with the virus causing genital herpes, with the rate one in five for women aged 35-44, a study said.
Epilepsy drug may increase risk of birth defects
Taking the epilepsy drug topiramate alone or along with other epilepsy drugs during pregnancy may increase the risk of birth defects, according to a study published in the July 22, 2008, issue of
Neurology, the medical journal of the American Academy of Neurology.
1 in 10 adults has a non-earlobe piercing
One in ten adults in England have had a piercing somewhere other than their ear lobe, with a quarter experiencing complications, and one in 100 piercings resulting in a hospital admission, according to a study published on bmj.com today.
Gene therapy 'trains' immune system to destroy brain cancer cells and reverses behavioral deficits
A new gene therapy approach that attracts and “trains” immune system cells to destroy deadly brain cancer cells also provides long-term immunity, produces no significant adverse effects and -- in the process of destroying the tumor -- promotes the return of normal brain function and behavioral skills, according to a study conducted by researchers at Cedars-Sinai Medical Center’s Board of Governors Gene Therapeutics Research Institute.
'Good bacteria' in women give clues for slowing HIV transmission
Beneficial bacteria found in healthy women help to reduce the amount of vaginal HIV among HIV-infected women and make it more difficult for the virus to spread, boosting the possibility that “good bacteria” might someday be tapped in the fight against HIV.
Genetic mutations may contribute to preterm birth risk
Genetic mutations in the enzyme methylenetetrahydrofoloate reductase (MTHFR) and coagulation protein Factor V appear to have significant association with blood clots and tissue injury to the placenta and developing baby, researchers from the University of Pittsburgh’s department of obstetrics, gynecology and reproductive sciences report at the 28th annual meeting of the Society for Maternal-Fetal Medicine.
A tricky tumor virus
Epstein-Barr virus (EBV) is a human-pathogenic virus which belongs to the herpes virus family. Almost every adult carries EBV inside. With an infestation rate of more than 90 %, EBV is one of the most successful human viruses. Its viral genome consists of double-stranded DNA, and it is one of the few known viruses which cause cancer in humans under certain circumstances. EBV-associated cancers include lymphomas (cancer of the lymph nodes), nasopharyngeal carcinoma and gastric cancer.